Yinshan Zhao, Ph.D.
Affiliations: | 2004 | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Area:
StatisticsGoogle:
"Yinshan Zhao"Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ng HS, Zhu F, Zhao Y, et al. (2024) Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis. Neurology. 102: e208006 |
| Yusuf FLA, Zhu F, Evans C, et al. (2023) Gastrointestinal conditions in the multiple sclerosis prodrome. Annals of Clinical and Translational Neurology |
| Graf J, Ng HS, Zhu F, et al. (2023) Multiple sclerosis disease-modifying drug use by immigrants: a real-world study. Scientific Reports. 13: 21235 |
| Chertcoff AS, Yusuf F, Zhu F, et al. (2023) Psychiatric Comorbidity During the Prodromal Period in Patients With Multiple Sclerosis. Neurology |
| Chertcoff A, Ng HS, Zhu F, et al. (2022) Polypharmacy and multiple sclerosis: A population-based study. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221122207 |
| Marrie RA, Allegretta M, Barcellos LF, et al. (2022) From the prodromal stage of multiple sclerosis to disease prevention. Nature Reviews. Neurology |
| Ng HS, Zhu F, Kingwell E, et al. (2022) Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival. Neurology(R) Neuroimmunology & Neuroinflammation. 9 |
| Liang G, Zhu F, Mirza AI, et al. (2022) Stability of the gut microbiota in persons with paediatric-onset multiple sclerosis and related demyelinating diseases. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221079533 |
| Ng HS, Graf J, Zhu F, et al. (2021) Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population. Frontiers in Immunology. 12: 794075 |
| Mirza AI, Zhu F, Knox N, et al. (2021) Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome. Neurology |